3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Neoplasm Metastasis
1
Heart Failure
1
Bradycardia
1
Atrioventricular Block
1
Interventions
sacubitril and valsartan sodium hydrate drug combination
3
Nutrition Assessment
3
Exercise
3
Carvedilol
3
dapagliflozin
2
Standard of Care
2
Rituximab
2
Ivabradine
2
Control Groups
2
Atorvastatin
2
pertuzumab
1
pegfilgrastim
1
obinutuzumab
1
nicotinamide-beta-riboside
1
empagliflozin
1
candesartan
1
acalabrutinib
1
Vincristine
1
Valsartan
1
Trastuzumab
1
Surveys and Questionnaires
1
Spironolactone
1
Sodium Chloride
1
Simendan
1
Secondary Prevention
1
Resistance Training
1
Pyruvic Acid
1
Prednisolone
1
Practice Guidelines as Topic
1
Population Groups
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Heart Failure
×
Cardiac Resynchronization Therapy
×
Clear all
NCT05966675
2025-06-08
PACE-4-TAVI
Medical University of Silesia
Phase NA
Recruiting
500 enrolled